v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Assets    
Cash and cash equivalents $ 2,137 $ 5,343
Accounts receivable, net 3,498 4,339
Non-trade receivable 9,841 7,119
Related party receivable 181
Inventory 10,986 10,621
Prepaid expenses and other current assets 3,839 4,562
Total current assets 30,301 32,165
Property and equipment, net 140 227
Contract fulfillment assets 9,053 6,399
Other assets 725 948
Total assets 40,219 39,739
Liabilities and stockholders’ equity (deficit)    
Accounts payable 20,408 22,848
Accrued liabilities 13,631 20,892
Promissory notes, net, current portion 4,817
Total current liabilities 38,856 43,740
Promissory notes, net 250
Income tax payable 1,814 1,699
Total liabilities 40,920 45,439
Commitments and contingencies (Note 8)
Stockholders’ equity (deficit)    
Common stock, $0.001 par value per share; 100,000,000 shares authorized; and 1,015,652 and 276,881 shares issued and outstanding at September 30, 2025, and December 31, 2024, respectively [1] 1
Preferred stock, $0.001 par value per share, 5,000,000 shares authorized, and no shares issued and outstanding at September 30, 2025, and December 31, 2024, respectively
Additional paid-in capital [1] 294,676 277,908
Accumulated deficit (295,378) (283,608)
Total stockholders’ equity (deficit) (701) (5,700)
Total liabilities and stockholders’ equity (deficit) $ 40,219 $ 39,739
[1] Adjusted retroactively to reflect the 1-for-18 reverse stock split that became effective on October 27, 2025, see Note 1.

Source